Literature DB >> 18053917

Diffuse lamellar keratitis after corneal crosslinking in a patient with post-laser in situ keratomileusis corneal ectasia.

George D Kymionis1, Dimitrios I Bouzoukis, Vasilios F Diakonis, Dimitra M Portaliou, Aristofanis I Pallikaris, Sonia H Yoo.   

Abstract

A 27-year-old man presented with corneal ectasia in his left eye 4 years after myopic laser in situ keratomileusis (LASIK) and was treated with riboflavin-ultraviolet-A (crosslinking). During the first post-treatment days, diffuse lamellar keratitis (DLK) (stage III) developed. The microbiology culture was negative. After intensive treatment with topical corticosteroids, the DLK resolved during the following 2 weeks. Crosslinking for post-LASIK corneal ectasia may induce DLK. Early diagnosis and appropriate treatment with intensive topical corticosteroids is essential to successfully manage this post-crosslinking complication.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18053917     DOI: 10.1016/j.jcrs.2007.06.070

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  21 in total

1.  Corneal collagen crosslinking for corneal ectasia of post-LASIK: one-year results.

Authors:  Gang Li; Zheng-Jun Fan; Xiu-Jun Peng
Journal:  Int J Ophthalmol       Date:  2012-04-18       Impact factor: 1.779

Review 2.  Corneal collagen crosslinking in keratoconus and other eye disease.

Authors:  Adel Alhayek; Pei-Rong Lu
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

3.  [Corneal scar development after cross-linking in keratoconus].

Authors:  F Raiskup; A Kissner; A Hoyer; E Spörl; L E Pillunat
Journal:  Ophthalmologe       Date:  2010-09       Impact factor: 1.059

4.  Herpetic keratitis after corneal collagen cross-linking with riboflavin and ultraviolet-A for progressive keratoconus.

Authors:  Nilay Yuksel; Kamil Bilgihan; Ahmet M Hondur
Journal:  Int Ophthalmol       Date:  2011-12-03       Impact factor: 2.031

5.  Corneal collagen cross-linking.

Authors:  Mirko R Jankov Ii; Vesna Jovanovic; Ljubisa Nikolic; Jonathan C Lake; Georgos Kymionis; Efekan Coskunseven
Journal:  Middle East Afr J Ophthalmol       Date:  2010-01

6.  Collagen cross-linking using riboflavin and ultraviolet-a for corneal thinning disorders: an evidence-based analysis.

Authors:  G Pron; L Ieraci; K Kaulback
Journal:  Ont Health Technol Assess Ser       Date:  2011-11-01

7.  Complications of corneal collagen cross-linking.

Authors:  Shikha Dhawan; Kavita Rao; Sundaram Natrajan
Journal:  J Ophthalmol       Date:  2011-12-27       Impact factor: 1.909

8.  Collagen cross-linking: current status and future directions.

Authors:  Marine Hovakimyan; Rudolf F Guthoff; Oliver Stachs
Journal:  J Ophthalmol       Date:  2012-01-12       Impact factor: 1.909

Review 9.  Diffuse Lamellar Keratitis in a Patient Undergoing Collagen Corneal Cross-Linking 18 Years After Laser In Situ Keratomileusis Surgery.

Authors:  Justin J Grassmeyer; John G Goertz; Brandon J Baartman
Journal:  Cornea       Date:  2021-07-01       Impact factor: 3.152

10.  Corneal absorption of a new riboflavin-nanostructured system for transepithelial collagen cross-linking.

Authors:  Katia M Bottos; Anselmo G Oliveira; Patrícia A Bersanetti; Regina F Nogueira; Acácio A S Lima-Filho; José A Cardillo; Paulo Schor; Wallace Chamon
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.